INMB vs ORLY · rev $50.0K vs P/E 34, rev $9.45B
INmune Bio Inc (INMB) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
INmune Bio Inc (INMB) is a biotechnology company listed on US.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported INMB revenue for 2025-09-30 was $50.0K. Net income was -$6.5M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. INMB currently screens at market cap $33.5M.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
INMB currently screens at market cap $33.5M. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the INMB and ORLY stock pages for the full models.
Not investment advice.